Skip to main content
. 2018 Oct 11;36:436–445. doi: 10.1016/j.ebiom.2018.09.010

Table 1.

Demographic and clinical characteristics of the studies included in this meta-analysis.

Study MDD subjects
HC
N Mean age (SD), years Female, N (%) Mean illness duration (SD), years Depression state Depression severity Medication status (%) Comorbidity (N) N Mean age (SD), years Female (N, %)
Samples from adolescents
Kim et al., 2015 [11] 22 13.9(1.6) 8(36) 6(1.6) Active CDI: 40.0 Medication-naïve (100%) Pure MDD 20 14.5(1.7) 6(30)
Pannekoek et al., 2014 [9] 26 15.4(1.5) 23(88) NA Active CDI: 18.6 Medication-naïve (100%) Anxiety (18) 26 14.7(1.5) 23(88.5)
Peters et al., 2016 [63] 23 15.61(1.9) 13(57) NA Remitted CDRS-R: 26.91 Medicated (52%) Anxiety (8) 10 15.8(1.99) 7(70)
Chattopadhyay et al., 2017 [64] 82 15.69(1.12) 64(78) NA Active SMFQ: 18.02 Medication-naïve (100%) Pure MDD 34 15.73(1.44) 27(100)
Cullen et al., 2014 [10] 41 15.7(2) 32(78) 0.83(0.9) Active CRDS: 77 Medication-naïve (73%) Anxiety (25) 29 16(2) 22(76)
Connolly et al., 2017 [65] 48 16.1(1.3) 29(60) NA Active CRDS: 70.2 Medication-naïve (100%) Anxiety (14), PTSD (5) 53 16.1(1.3) 33(62)
Cullen et al., 2009 [66] 12 16.5(0.95) 9(75) 2.2(2.2) Active CRDS: 77 Medicated (84%) Anxiety (10) 14 16.8(1.5) 8(57)
Straub et al., 2017 [67] 19 16.76(1.39) 15(79) NA Active CRDS: 55.91 Drug-free Phobia (5) 19 16.35(1.47) 15(79)



Samples from adults
Zhang X et al., 2014 [7] 32 20.53(1.78) 18(56) NA Active CES-D: 38.03 Medication-naïve (100%) Pure MDD 35 20.97(1.29) 17(49)
Jacobs et al., 2016(a) [68] 17 22.35(1.80) 11(65) 3.13 Active HAMD: 18.65 Medicated (36%) Anxiety (15) 26 21.15(1.49) 14(54)
Jacobs et al., 2016(b) [68] 34 21.06(1.54) 25(74) 7.97 Remitted HAMD: 2.35 Medicated (62%) Anxiety (12) 26 21.15(1.49) 14(54)
Ye J et al., 2017 (YA) [18] 34 24.15(2.84) 17(50) NA Active HAMD: 23.59 Medication-naïve (100%) Pure MDD 35 24.8(2.14) 18(51)
Altinay et al., 2016 [69] 15 27(10) 9(60) NA Active HAMD: 20 Drug-free Anxiety (15), PTSD (1) 15 29(8) 9(60)
Deligiannidis et al., 2013 [70] 8 28.62(5.93) 8(100) NA Active QIDS: 11.3 Drug-free Anxiety (4), PTSD (1) 9 30.67(3.81) 9(100)
Tang Y et al., 2013 [8] 28 29.3(8.7) 16(57) 1.13(1.3) Active HAMD: 29 Medication-naïve (100%) Pure MDD 30 30.1(8.4) 15(50)
Lui S et al., 2011 (NRD) [71] 32 32(10) 11(34) 1.83(1.5) Active HAMD: 23.0 Medication-naïve (100%) Pure MDD 48 35(12) 17(35)
Wang Y et al., 2016 [72] 25 32.11(11.25) 11(44) 0.7(0.2) Active HAMD: 29.32 NA Pure MDD 35 33.28(8.83) 16(46)
Lui S et al., 2011 (RD)[71] 28 33(11) 10(37.5) 16.08(10) Active HAMD: 23.3 Medication-naïve (100%) Pure MDD 48 35(12) 17(35)
Ramasubbu et al., 2014 [17] 55 36.5(10.4) 33(60) 4.19(5) Active HAMD: 21.41 Drug-free Pure MDD 19 32.89(9.97) 11(58)
Ye J et al., 2017 (OA)[18] 35 37.14(4.15) 26(74) NA Active HAMD: 23.69 Medication-naïve (100%) Pure MDD 46 37.22(4.44) 36(78)
Yang J et al., 2017 [73] 35 44.54(11.15) 35(100) 2.68(3.8) Active HAMD: 28.29 Drug-free Pure MDD 23 39.09(14.3) 23(100)
Tahmasian et al., 2013 [36] 21 51(15) 11(52) 14.7(11) Active HAMD: 23.8 Medicated (95%) Anxiety (6),somatization disorder (2),personality disorder (5) 20 49.6(13.9) 11(55)

Abbreviations: N, numbers; CDI, Children's Depression Inventory; CDRS-R, Children's Depression Rating Scale-Revised; CDRS, Children's Depression Rating Scale; SMFQ, Short Mood and Feeling Questionnaire; CES-D, Center for Epidemiological Studies Depression Scale; HAMD, Hamilton Rating Scale for Depression; QIDS, Quick Inventory Depressive Symptoms; NA, not available; YA, young adult; NRD, nonrefractory depression; RD, refractory depression; OA, older adults.